Want to join the conversation?
Medical technology company $MDT said that it announced CE Mark and commercial launch for the Resolute Onyx DES, a next-gen drug-eluting stent, which is not commercially available in the US. The CE Mark also approved several new product indications, including treatment of left main vessels and small vessels of the heart.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.